All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Sleeping Beauty (SB) transposon, a type of nonviral integrative vectors, provides an alternative to modify primary T cells. Creative biolabs has developed SB transposon CAR vector pSBCAR1 CEA (H10) h(28OXζ), which is constructed for the engineering of T cells to target human CEA. The T cells are genetically modified through transduction with a nonviral vector expressing scFv of anti-CEA antibody linked to a CD28 transmembrane domain/ endodomain and OX40, CD3-zeta signaling domains. And the vector product was designed for the treatment of Pancreatic cancer.
CAR Construction : Fig.2 Monitoring of the formation of multimeric biotinylated scFv using streptavidin molecules. The percentage specific binding of 125I-labeled streptavidin to purified CEA-sepharose was obtained by subtracting the percentages detected on control BSA-Sepharose from those measured on CEA-Sepharose. Cloutier, S. M., Couty, S., Terskikh, A., Marguerat, L., Crivelli, V., Pugnieres, M., ... & Deperthes, D. (2000). Streptabody, a high avidity molecule made by tetramerization of in vivo biotinylated, phage display-selected scFv fragments on streptavidin. Molecular immunology, 37(17), 1067-1077. |
CAR Construction : Fig.3 Competitive inhibition of binding of 125I-labeled mAb 35A7 to CEA–Sepharose in the presence of different scFv and streptabody concentrations. All measurements were performed in triplicate. Cloutier, S. M., Couty, S., Terskikh, A., Marguerat, L., Crivelli, V., Pugnieres, M., ... & Deperthes, D. (2000). Streptabody, a high avidity molecule made by tetramerization of in vivo biotinylated, phage display-selected scFv fragments on streptavidin. Molecular immunology, 37(17), 1067-1077. |
CAR Construction : Fig.4 Analysis of the CEA-binding behavior of the scFvs (BAD) and Streptabodies with surface plasmon resonance on a Biacore biosensor instrument. All measurements were performed in triplicate. Cloutier, S. M., Couty, S., Terskikh, A., Marguerat, L., Crivelli, V., Pugnieres, M., ... & Deperthes, D. (2000). Streptabody, a high avidity molecule made by tetramerization of in vivo biotinylated, phage display-selected scFv fragments on streptavidin. Molecular immunology, 37(17), 1067-1077. |
CAR Construction : Fig.5 Binding of antibodies to captured cell membrane vesicles. Anti-CD30 Ki-4 diabody and Ki-4 Moab, as well as PBS and anti-CEA H10 scFv were sequentially passed over flow cell 1 and flow cell 2. The absolute response signals on both flow cells were subtracted from each other in real time (flow cell 2 - flow cell 1) and subsequently X- and Y-transformed using BIAeval 3.1 program. Klimka, A., Tur, M. K., Huhn, M., Bierfreund, U., Terrada, E., Fischer, R., ... & Barth, S. (2004). Measurement of antibody-membrane interactions by surface plasmon resonance. International journal of molecular medicine, 14(4), 765-773. |
CAR Construction : Fig.1 Peripheral blood T cells were grafted by retroviral gene transfer with the CEA specific immunoreceptor H10-scFv-Fc-ζ. To monitor receptor expression, T cells were simultaneously incubated with a FITC-conjugated anti-CD3 mAb and a PE-conjugated anti-human IgG1 Ab directed against the extracellular Fc domain of the receptor. Cells were analyzed by flow cytometry. Hombach, A. A., Schildgen, V., Heuser, C., Finnern, R., Gilham, D. E., & Abken, H. (2007). T cell activation by antibody-like immunoreceptors: the position of the binding epitope within the target molecule determines the efficiency of activation of redirected T cells. The Journal of Immunology, 178(7), 4650-4657. |
More Published Data More Published Data
There are currently no customer reviews or questions for Anti-CEA (H10) h(CD28-OX40-CD3ζ) CAR, pSBCAR1 (CAR-SB-02LX359). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION